Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGYG.L Regulatory News (GYG)

  • There is currently no data for GYG

Pre-Close Period Statement

14 Jul 2006 07:00

Gyrus Group PLC14 July 2006 14th July 2006 Gyrus Group PLC Pre-Close Period Statement Reading, UK - Gyrus Group (GYG.L) a leading supplier of medical devices whichreduce trauma and complications in surgery, today provides a pre-close periodupdate ahead of its interim results announcement on 12th September 2006. The Group's reported revenues for the six months to 30th June 2006 areanticipated to be approximately £107 million representing growth of over 125% onthe previous year (2005: £47.3 million). Proforma organic revenue growth (whichassumes a full period comparative for the ACMI business which was acquired on21st July 2005) is expected to be marginally over 10%. The legacy Gyrusbusinesses grew revenue by approximately 17% over the first half of 2005 (12% ona constant exchange rate basis). Good performances from the Group's proprietaryDivisions in the US and the Partnered Technologies Division were partly offsetby a weaker performance in international markets, where the integration ofinternational distributors during the period caused a shortfall in revenues. The Surgical Division's new PlasmaCision-derived products (G400 generator,Plasma Trissector, Plasma J Hook) were introduced to the general surgery marketin late March and the technology has been well received during this initialevaluation phase. At the end of the period there were approximately 100 G400generators either placed or sold into the surgical market and the divisionachieved revenue in excess of $1 million from the PlasmaCision portfolio. The Urology & Gynaecology Division had a slower first half when compared to astrong 2005 result pre-acquisition, however the adoption of PK SuperPulse intothe legacy ACMI urology accounts has started well with sales in excess of theCompany's forecasts. New product introductions, including the early evaluationof the new digital ureteroscope, show significant potential for the second halfof 2006. The integration programme has continued on track and savings from this, togetherwith revenue orientated towards more profitable US domestic disposables sales,is expected to result in a significant enhancement to operating profitability. Subject to any unforeseen adjustments it is anticipated that underlying "adjusted" earnings per share (excluding amortisation of acquired intangibleassets, integration costs and deferred tax adjustments) for the six months to30th June 2006 will be in line with consensus expectations, which currentlystand at 7.3 pence per share (H1 2005: 5.1 pence). Brian Steer, Executive Chairman of Gyrus said: "The first half of 2006 has been a successful period of change; we have madesignificant inroads into the integration programme and have started tore-orientate the legacy ACMI business towards our disposable devices businessmodel. At the same time we have successfully introduced our important newPlasmaCision technology. In addition, we look forward to a number of potentiallysignificant new product launches in the second half of 2006." Enquiries: Gyrus Group PLCBrian Steer Executive Chairman 01189 219 750Simon Shaw Chief Financial Officer 01189 219 750 Financial DynamicsBen Atwell 0207 269 7242 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
31st Jan 20074:16 pmRNSTotal Voting Rights
29th Jan 200711:01 amRNSHolding(s) in Company
25th Jan 200710:31 amRNSHolding(s) in Company
24th Jan 20074:15 pmRNSHolding(s) in Company
22nd Jan 200712:48 pmRNSHolding(s) in Company
22nd Jan 200710:44 amRNSHolding(s) in Company
16th Jan 20077:00 amRNSPre-Close Period Statement
20th Dec 20064:00 pmRNSTotal Voting Rights
18th Dec 20061:52 pmRNSBlocklisting Interim Review
14th Nov 200612:47 pmRNSDirector/PDMR Shareholding
31st Oct 20063:54 pmRNSHolding(s) in Company
25th Oct 200610:03 amRNSHolding(s) in Company
24th Oct 20067:02 amRNSHolding(s) in Company
23rd Oct 20063:52 pmRNSAnalyst & Investor Teach-In
18th Oct 20063:07 pmRNSRe: Appointment
17th Oct 20061:54 pmRNSRe Appointment
17th Oct 20061:34 pmRNSBoard Appointment
17th Oct 20061:31 pmRNSBoard Appointment
10th Oct 200612:35 pmRNSHolding(s) in Company
10th Oct 20067:00 amRNSAnalyst Site Visit
26th Sep 20065:24 pmRNSHolding(s) in Company
12th Sep 20067:04 amRNSInterim Results
6th Sep 20067:03 amRNSLawsuit Settlement
4th Sep 20067:01 amRNSChange of Adviser
24th Aug 20066:28 pmRNSHolding(s) in Company
26th Jul 20065:37 pmRNSAdditional Listing
20th Jul 200611:02 amRNSHolding(s) in Company
14th Jul 20067:00 amRNSPre-Close Period Statement
29th Jun 20068:42 amRNSHolding(s) in Company
27th Jun 20061:38 pmRNSHolding(s) in Company
15th Jun 20064:05 pmRNSAnnual Information Update
7th Jun 20063:58 pmRNSAdditional Listing
6th Jun 20063:35 pmRNSAdditional Listing
6th Jun 20063:34 pmRNSAdditional Listing
26th May 20062:29 pmRNSDirector/PDMR Shareholding
24th May 20067:02 amRNSRe Agreement
3rd May 200611:49 amRNSResult of AGM
16th Mar 20067:01 amRNSFinal Results
1st Mar 200612:34 pmRNSNotice of Results
24th Feb 20064:14 pmRNSHolding(s) in Company
16th Feb 200612:59 pmRNSHolding(s) in Company
8th Feb 200612:47 pmRNSHolding(s) in Company
31st Jan 200610:44 amRNSHolding(s) in Company
19th Jan 20068:54 amRNSHolding(s) in Company
16th Jan 20067:00 amRNSPre-Close Update
11th Jan 20062:36 pmRNSHolding(s) in Company
8th Dec 20055:47 pmRNSHolding(s) in Company
28th Nov 20054:37 pmRNSHolding(s) in Company
23rd Nov 200512:03 pmRNSHolding(s) in Company
23rd Nov 20057:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.